Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly logo
Allergy Shot Alternative with Sublingual Treatment Plans | Wyndly Updated August 04, 2026

Doctor‑supervised SLIT for environmental allergies (what it means)

Introduction

At Wyndly, SLIT is doctor‑supervised, delivered by board‑certified allergists, and tailored from testing to dosing. We use FDA‑approved SLIT tablets when appropriate and clinically proven drops for multi‑allergen care. Safety is central: first tablet dose observed (≥30 minutes), and epinephrine training, plus 24/7 access to your physician. You’ll complete a CLIA‑certified at‑home test, meet your doctor online, and start a personalized plan that gradually desensitizes you to pollen, dust mites, pets, and molds. Most patients notice improvement in 4–24 weeks, with durable control after about 3 years. This page explains protocols, eligibility, and evidence, and links to our Immunotherapy hub and FAQ. Ages 5+, environmental allergies only; tablets treat single allergens; drops can address multiple triggers safely at home daily.

What “doctor‑supervised SLIT” means at Wyndly

  • Care led by US board‑certified physicians with ongoing check‑ins and 24/7 access for questions and urgent concerns (text, email, phone). See our Patient FAQ.

  • Evidence‑based protocols using FDA‑approved sublingual tablets (for specific allergens like grasses, ragweed, dust mites) and clinically proven, physician‑directed drops for multi‑allergen desensitization. See our Immunotherapy hub and SLIT vs shots overview.

  • End‑to‑end oversight: CLIA‑certified at‑home IgE test, physician review, personalized plan, pharmacy fulfillment, and outcome monitoring.

Protocols by modality

  • SLIT drops (multi‑allergen)

  • Daily, at home; typical improvement in 4–24 weeks; course ~3 years for durable relief. Low risk of severe reactions; local mouth/throat itching is most common and usually mild. Wyndly’s safety overview details the very low anaphylaxis rates reported for drops.

  • SLIT tablets (single‑allergen; FDA‑approved)

  • Induction: first tablet dose observed (≥30 minutes) with a clinician; epinephrine training provided; ongoing daily dosing at home thereafter. This reflects standard US practice for SLIT tablets and aligns with patient‑education resources on SLIT.

Modality Covers First‑dose monitoring Where taken Key notes
SLIT drops Multiple environmental allergens (pets, pollens, dust, molds) Not required due to favorable safety profile Home Physician‑directed dosing; convenient for multi‑allergen care
SLIT tablets Single allergen (e.g., grass, ragweed, dust mite) Required: observed ≥30 minutes; epinephrine training First dose in clinic; rest at home FDA‑approved products; daily adherence critical

References and details: Immunotherapy hub and Patient FAQ.

Eligibility, inclusions, and exclusions

  • We treat environmental allergies only (pollen, pet dander, dust mites, molds); no food allergy treatment.

  • Ages 5+ are eligible for SLIT. Typical exclusions: eosinophilic esophagitis (EoE), mast cell activation syndrome (MCAS), pregnancy, or beta‑blocker therapy (your doctor will screen for safety). See eligibility notes in our pollen SLIT overview and FAQ.

What to expect: step‑by‑step

1) At‑home CLIA‑certified allergy test (finger‑prick). 2) Online visit with a Wyndly doctor to interpret results and finalize your plan. 3) Pharmacy prepares your personalized drops/tablets and ships to your door every 12 weeks. 4) Daily dosing at home; check‑ins and anytime access to your care team. 5) Timelines: many notice improvement in 4–24 weeks; plan on ~3 years for durable, long‑term immune change. Details in our Immunotherapy hub and state/city guides.

Evidence and guidance (high level)

  • Major reviews (e.g., Cochrane) and US specialty guidelines recognize SLIT as effective and safe for environmental allergies; Wyndly follows AAO‑HNS clinical practice guidance and uses FDA‑approved SLIT tablets where indicated, with rigorous physician oversight. See our Immunotherapy hub and FAQ.

  • Practical safety distinctions: tablets require an observed first dose and epinephrine training; drops have an excellent safety profile suitable for home use, with severe reactions exceedingly rare in published data. Safety notes and timelines appear throughout our FAQ.

Get started

  • Explore protocols, safety, and scientific evidence on our Immunotherapy hub.

  • For logistics, timelines, side‑effects, eligibility, and refills, read the Patient FAQ.

  • When ready, schedule your visit to review your results and treatment options with a Wyndly doctor.